The genetically engineered salmon, also known as the "Frankenfish," has come one step closer to the supermarket shelves. Canada's environmental regulatory agency will permit AquaBounty to produce genetically engineer salmon eggs on a commercial scale at a hatchery on Prince Edward Island.
The "AquAdvantage" salmon is not yet for sale to the public. The salmon is still waiting to be approved or rejected by the Food and Drug Administration before it can be sold in the U.S.
AquaBounty calls the announcement a "significant milestone" in its press release, adding that the facility will produce sterile, all-female eggs.
The Gazette reports that currently salmon eggs are being exported from the Prince Edward Island hatchery to a research and development facility in Panama where the fish are raised. If the FDA approves AquAdvantage, the company will also seek approval from the local Panama government to raise and process the fish there.
The genetically engineered fish has come up against strong opposition from consumer advocates and environmental groups. During the FDA's public comment period, which closed in April, 1.5 million objections were filed against AquAdvantage.